Abortion (obstetrics)

Reading Document
Medical Text Search

abortion obstetrics classification types spontaneous threatened inevitable

Medical Text Search

abortion management diagnosis etiology complications

GradeResponse
GradeResponse
The retrieval returned limited content, so I'll provide a comprehensive answer from established medical knowledge, supplemented by the retrieved source.

Abortion (Obstetrics)

In obstetrics, abortion refers to the termination of pregnancy before 20–24 weeks of gestation (viability threshold varies by jurisdiction) or with a fetal weight <500 g. It is classified as either spontaneous or induced.

Classification

By Etiology

TypeDescription
Spontaneous abortion (miscarriage)Non-deliberate pregnancy loss before viability
Induced abortionDeliberate termination — medical or surgical; may be elective or for clinical indications (e.g., missed abortion, IUFD)
According to Abortion Care (p. 102), abortion management is needed for both induced and spontaneous abortion, including clinical indications such as missed abortion and intrauterine fetal demise.

By Clinical Presentation (Spontaneous Abortion)

TypeCervical OsBleedingTissue PassedViability
ThreatenedClosedPresentNonePossible
InevitableOpenPresentNoneNot possible
IncompleteOpenPresentPartial passageNot possible
CompleteClosed (after)ResolvingAll passedN/A
Missed (silent)ClosedMinimal/noneNoneDead embryo/fetus retained
SepticVariableVariableVariableInfection superimposed
Recurrent (habitual)≥3 consecutive losses
Blighted ovum (anembryonic)ClosedMinimalNoneEmpty gestational sac

Epidemiology

  • Spontaneous abortion occurs in 10–15% of clinically recognized pregnancies; estimates rise to ~30% when biochemical pregnancies are included.
  • The majority (>80%) occur in the first trimester.
  • Risk increases sharply with advancing maternal age (>35 years).

Etiology

First Trimester Spontaneous Abortion

  1. Chromosomal abnormalities — most common cause (~50–60%); trisomies (especially 16, 18, 21), monosomy X (Turner), triploidy
  2. Structural uterine anomalies — septate uterus, fibroids (submucosal), Asherman syndrome
  3. Endocrine factors — uncontrolled diabetes, thyroid dysfunction, luteal phase defect, hyperprolactinemia
  4. Antiphospholipid syndrome (APS) — recurrent pregnancy loss with thrombophilia
  5. Infections — TORCH (Toxoplasma, Rubella, CMV, HSV), Listeria, Mycoplasma, Chlamydia
  6. Immunological — alloimmune factors, NK cell dysfunction
  7. Environmental/toxic — smoking, alcohol, radiation, heavy metals
  8. Thrombophilias — Factor V Leiden, prothrombin gene mutation, protein C/S deficiency
  9. Unexplained — significant proportion remain without identifiable cause

Second Trimester (Late) Abortion

  • Cervical incompetence (insufficiency)
  • Uterine anomalies
  • PPROM
  • Antiphospholipid syndrome

Clinical Features

Threatened Abortion

  • Vaginal bleeding in early pregnancy (any amount)
  • Cervical os closed
  • Uterine size consistent with dates
  • Cramping may or may not be present

Inevitable Abortion

  • Profuse bleeding + cramping
  • Cervical os open
  • Membranes may be bulging or ruptured

Incomplete Abortion

  • Partial expulsion of products of conception (POC)
  • Open os with ongoing bleeding
  • Endometrial thickness >15 mm on ultrasound often indicates retained POC

Missed Abortion

  • Asymptomatic; diagnosed on ultrasound
  • Crown-rump length (CRL) ≥7 mm with no fetal cardiac activity
  • Mean sac diameter ≥25 mm with no embryo

Septic Abortion

  • Fever, uterine tenderness, purulent discharge
  • May progress to septicemia, endotoxic shock, DIC, renal failure
  • Causative organisms: Staphylococcus aureus, E. coli, Clostridium perfringens, anaerobes

Diagnosis

History

  • LMP, gestational age, bleeding amount, passage of tissue, associated pain
  • Previous obstetric history, APS, structural abnormalities

Examination

  • Speculum: os open/closed, tissue at os, bleeding
  • Bimanual: uterine size, tenderness, cervical motion tenderness

Investigations

InvestigationPurpose
Transvaginal ultrasound (TVUS)First-line; confirms viability, location, fetal cardiac activity
Serum β-hCG (serial)Normally doubles every 48–72h; plateau/fall = non-viable/ectopic
CBCAssess hemorrhage, infection (leukocytosis in septic)
Blood group + RhAnti-D prophylaxis planning
ProgesteroneLow levels (<5 ng/mL) suggest non-viability
Coagulation screenIn missed abortion >4 weeks (DIC risk)
CulturesBlood, endocervical swabs in septic abortion

Management

Threatened Abortion

  • Supportive: pelvic rest, avoid intercourse
  • No proven intervention to prevent loss if chromosomally abnormal
  • Progesterone supplementation (vaginal micronized) may benefit in women with prior miscarriage and subchorionic hematoma
  • Serial β-hCG and ultrasound

Inevitable / Incomplete Abortion

Options:
  1. Expectant management — allow natural expulsion; takes days to weeks; suitable if hemodynamically stable
  2. Medical managementMisoprostol (800 mcg vaginal/sublingual); highly effective for first-trimester incomplete/inevitable abortion; success 80–90%
  3. Surgical management — Manual vacuum aspiration (MVA) or suction curettage (EVA); sharp curettage now less preferred due to Asherman syndrome risk

Missed Abortion

  • All three options (expectant, medical, surgical) are acceptable
  • Medical: Mifepristone 200 mg PO → Misoprostol 800 mcg 24–48h later (combination more effective)
  • Surgical: MVA or EVA under local/general anesthesia

Complete Abortion

  • Confirm by ultrasound (endometrial thickness <15 mm, closed os)
  • Expectant; no further intervention usually needed

Septic Abortion

  • Emergency — IV broad-spectrum antibiotics (e.g., ampicillin + gentamicin + metronidazole)
  • Prompt uterine evacuation (surgical) after antibiotic initiation
  • ICU-level care if septic shock, DIC, or multiorgan dysfunction
  • Rule out clostridial infection (gas in uterine wall on imaging)

Rh Isoimmunization Prevention

  • All Rh-negative unsensitized women with spontaneous or induced abortion should receive anti-D immunoglobulin (50 mcg if <12 weeks; 300 mcg if ≥12 weeks)

Recurrent Pregnancy Loss (RPL)

Defined as ≥3 consecutive losses before 20 weeks (some societies use ≥2).

Investigation

CauseInvestigation
Antiphospholipid syndromeAnticardiolipin Ab, anti-β2GP1 Ab, lupus anticoagulant
ThrombophiliaFactor V Leiden, prothrombin mutation, protein C/S, antithrombin
Uterine structuralHysteroscopy, 3D ultrasound, MRI
Parental karyotypeChromosomal translocations
EndocrineTSH, prolactin, HbA1c

Management of RPL

  • APS confirmed: Low-dose aspirin + LMWH throughout pregnancy
  • Inherited thrombophilia: LMWH if loss history is severe
  • Uterine septum: Hysteroscopic metroplasty
  • Unexplained RPL: Supportive care in dedicated early pregnancy unit improves outcomes; empirical progesterone (PROMISE trial: equivocal; PRISM trial: modest benefit in women with prior loss + bleeding)

Complications

ComplicationNotes
HemorrhageMay require blood transfusion, uterotonic agents, or surgical intervention
Infection / SepsisEndometritis → septicemia → DIC; highest risk in septic/incomplete abortion
Asherman syndromeIntrauterine adhesions after vigorous curettage
Cervical/uterine traumaWith surgical management
DICEspecially in missed abortion retained >4–6 weeks, septic abortion
Psychological sequelaeGrief, depression, anxiety — especially after recurrent loss
Rh sensitizationIf anti-D prophylaxis omitted in Rh-negative women

Key Points Summary

  • Most common cause of first-trimester spontaneous abortion: chromosomal abnormality (~50–60%)
  • Diagnostic gold standard: Transvaginal ultrasound
  • Medical management: Misoprostol ± Mifepristone
  • Surgical management: MVA preferred over sharp curettage
  • Septic abortion: Antibiotics first, then urgent evacuation
  • Anti-D prophylaxis: Mandatory in all Rh-negative women
  • RPL workup: APS, thrombophilia, uterine anatomy, parental karyotype
This is a shared conversation. Sign in to Orris to start your own chat.